Who owns DOGWOOD THERAPEUTICS INC?
- Ticker: DWTX
- CUSIP Number: 92829j203
Tip: Access positions for across all investors
Analyze quarterly positions in Dogwood Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Dogwood Therapeutics stock
Who bought or sold DOGWOOD THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Armistice Capital | 3.3M | $6.9M | 100% | Mar 2026 |
|
| Vanguard Capital Management | 132k | $279k | 100% | Mar 2026 |
|
| Geode Capital Management | 79k | $168k | 373% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 63k | $132k | 100% | Mar 2026 |
|
| Vanguard Group | 30k | $125k | 35% | Dec 2025 |
|
| Goldman Sachs Group | 15k | $31k | 100% | Mar 2026 |
|
| Marshall Wace | 12k | $49k | 100% | Dec 2025 |
|
| UBS Group | 7.1k | $15k | 305% | Mar 2026 |
|
| Activest Wealth Management | 120.00 | $252.996000 | 0% | Mar 2026 |
|
| BlackRock | 30.00 | $63.000000 | 0% | Mar 2026 |
|
| Group One Trading | 9.00 | $18.999900 | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 2.00 | $4.000000 | 0% | Mar 2026 |
|
Who sold out of Dogwood Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Tower Research Capital | Sep 2025 | 744.00 | $5.7k |
| Morgan Stanley | Dec 2025 | 477.00 | $2.0k |
| Barclays | Sep 2025 | 5.00 | $39.000000 |